|
US3705185A
(en)
|
1969-04-14 |
1972-12-05 |
Minnesota Mining & Mfg |
N-aroyl sulfonamides
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
GB8524157D0
(en)
|
1984-10-19 |
1985-11-06 |
Ici America Inc |
Heterocyclic amides
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
DK24089D0
(da)
|
1989-01-20 |
1989-01-20 |
Hans Bundgaard |
Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
|
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
|
EP0567997A1
(de)
|
1992-04-30 |
1993-11-03 |
Hoechst Aktiengesellschaft |
4- oder 5-(Sulf)imido- und (Sulfon)amidopyridine, sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE69328430T2
(de)
|
1992-07-27 |
2001-01-25 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Zielgerichte liposome zur blut-hirne schranke
|
|
PT669920E
(pt)
|
1992-11-23 |
2003-06-30 |
Aventis Pharma Inc |
3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
|
|
US5573653A
(en)
|
1994-07-11 |
1996-11-12 |
Sandoz Ltd. |
Electrochemical process for thiocyanating aminobenzene compounds
|
|
GB9514160D0
(en)
*
|
1994-07-25 |
1995-09-13 |
Zeneca Ltd |
Aromatic compounds
|
|
ATE253057T1
(de)
|
1994-08-30 |
2003-11-15 |
Sankyo Co |
Isoxazole
|
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
GB9828442D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
JP4316787B2
(ja)
|
2000-01-11 |
2009-08-19 |
壽製薬株式会社 |
エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
WO2002015902A1
(en)
*
|
2000-08-23 |
2002-02-28 |
Merck & Co., Inc. |
Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
|
|
AU2001286930A1
(en)
|
2000-08-30 |
2002-03-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
EP1554572B1
(en)
|
2001-07-25 |
2009-10-14 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
KR100789567B1
(ko)
|
2001-11-06 |
2007-12-28 |
동화약품공업주식회사 |
3-아미도-1,2-벤조이소옥사졸 유도체, 그 염, 제조방법 및 용도
|
|
DE10201550A1
(de)
|
2002-01-17 |
2003-07-31 |
Merck Patent Gmbh |
Phenoxy-Piperidine
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
EP1529049B1
(en)
|
2002-08-08 |
2009-11-18 |
Memory Pharmaceuticals Corporation |
Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
|
|
KR101111477B1
(ko)
|
2002-12-03 |
2012-02-23 |
블랜체트 록펠러 뉴로사이언시즈 인스티튜트 |
치료제와 연결된 콜레스테롤을 포함하는 접합체
|
|
CN100469770C
(zh)
*
|
2002-12-12 |
2009-03-18 |
霍夫曼-拉罗奇有限公司 |
5-取代的-吡嗪或吡啶葡糖激酶激活剂
|
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
CA2521915A1
(en)
|
2003-04-15 |
2004-10-28 |
Pfizer Inc. |
Alpha substituted carboxylic acid as ppar modulators
|
|
ZA200601942B
(en)
|
2003-08-08 |
2007-05-30 |
Vertex Pharma |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
CA2539227A1
(en)
|
2003-08-08 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
US20050089473A1
(en)
|
2003-09-10 |
2005-04-28 |
Cedars-Sinai Medical Center |
Potassium channel mediated delivery of agents through the blood-brain barrier
|
|
EP1668002B1
(en)
|
2003-10-03 |
2009-11-11 |
Portola Pharmaceuticals, Inc. |
2,4-dioxo-3-quinazolinylaryl sulfonylureas
|
|
US7081539B2
(en)
|
2004-03-25 |
2006-07-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
|
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
|
EP1773792A1
(en)
|
2004-07-30 |
2007-04-18 |
Merck & Co., Inc. |
Indanone potentiators of metabotropic glutamate receptors
|
|
DE602005020313D1
(de)
|
2004-08-12 |
2010-05-12 |
Amgen Inc |
Bisaryl-sulfonamide
|
|
JP2008514703A
(ja)
|
2004-09-29 |
2008-05-08 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
置換２ｈ−１，３−ベンゾオキサジン−４（３ｈ）−オン
|
|
JP2008189549A
(ja)
|
2005-05-12 |
2008-08-21 |
Astellas Pharma Inc |
カルボン酸誘導体またはその塩
|
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
EP1922311A2
(en)
|
2005-09-09 |
2008-05-21 |
Brystol-Myers Squibb Company |
Acyclic ikur inhibitors
|
|
BRPI0617482A2
(pt)
|
2005-10-19 |
2011-07-26 |
Hoffmann La Roche |
compostos inibidores de transcriptase reversa nço-nucleosÍdeos de n-fenil fenilacetamida, composiÇço farmacÊutica contendo os referidos compostos bem como seus usos
|
|
AU2006318527A1
(en)
|
2005-11-23 |
2007-05-31 |
Ligand Pharmaceuticals Incorporated |
Thrombopoietin activity modulating compounds and methods
|
|
AR058296A1
(es)
|
2005-12-09 |
2008-01-30 |
Kalypsys Inc |
Inhibidores de histona desacetilasa y composicion farmaceutica
|
|
MX2008013194A
(es)
|
2006-04-11 |
2008-12-01 |
Vertex Pharma |
Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
|
|
US7700593B2
(en)
|
2006-10-11 |
2010-04-20 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use thereof
|
|
EP2108019A2
(en)
|
2007-01-30 |
2009-10-14 |
Biogen Idec MA, Inc. |
1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
|
|
CL2008000369A1
(es)
|
2007-02-05 |
2008-04-18 |
Xenon Pharmaceuticals Inc |
Compuestos derivados de piridopirimidinonas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dolor, depresion, enfermedades cardiovasculares, enfermedades respiratorias y enfermedades psiquiatricas.
|
|
CA2681572C
(en)
|
2007-03-23 |
2014-02-11 |
Icagen, Inc. |
Inhibitors of ion channels
|
|
CA2687764A1
(en)
|
2007-05-25 |
2008-12-04 |
Vertex Pharmaceuticals Incorporated |
Ion channel modulators and methods of use
|
|
WO2008149965A1
(ja)
*
|
2007-06-07 |
2008-12-11 |
Astellas Pharma Inc. |
ピリドン化合物
|
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
|
TW200911766A
(en)
|
2007-07-13 |
2009-03-16 |
Astrazeneca Ab |
New compounds
|
|
US8124610B2
(en)
|
2007-07-13 |
2012-02-28 |
Icagen Inc. |
Sodium channel inhibitors
|
|
US20110092703A1
(en)
|
2007-08-10 |
2011-04-21 |
Nippon Chemiphar Co., Ltd. |
P2x4 receptor antagonist
|
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
JP5375824B2
(ja)
*
|
2008-05-14 |
2013-12-25 |
アステラス製薬株式会社 |
アミド化合物
|
|
EP2305641A4
(en)
|
2008-06-23 |
2012-08-22 |
Astellas Pharma Inc |
SULPHONAMIDE COMPOUND OR SALT THEREOF
|
|
WO2010022055A2
(en)
|
2008-08-20 |
2010-02-25 |
Amgen Inc. |
Inhibitors of voltage-gated sodium channels
|
|
HUE025013T2
(hu)
|
2009-01-12 |
2016-04-28 |
Pfizer Ltd |
Szulfonamid-származékok
|
|
EA025824B1
(ru)
|
2009-07-27 |
2017-02-28 |
Джилид Сайэнс, Инк. |
Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
|
|
US8809380B2
(en)
|
2009-08-04 |
2014-08-19 |
Raqualia Pharma Inc. |
Picolinamide derivatives as TTX-S blockers
|
|
JP5708936B2
(ja)
*
|
2009-09-25 |
2015-04-30 |
アステラス製薬株式会社 |
置換アミド化合物
|
|
WO2011059042A1
(ja)
|
2009-11-12 |
2011-05-19 |
武田薬品工業株式会社 |
芳香環化合物
|
|
WO2011063001A1
(en)
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
PL2533638T3
(pl)
|
2010-02-12 |
2016-08-31 |
Nivalis Therapeutics Inc |
Nowe inhibitory reduktazy S-nitrozoglutationowej
|
|
WO2011153588A1
(en)
|
2010-06-10 |
2011-12-15 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
|
JP2013530013A
(ja)
|
2010-06-30 |
2013-07-25 |
カーディアック ペースメイカーズ， インコーポレイテッド |
優先的屈曲領域を有するコイル電極付リード
|
|
US9279003B2
(en)
|
2010-07-07 |
2016-03-08 |
Purdue Pharma L.P. |
Analogs of sodium channel peptide toxin
|
|
US9145407B2
(en)
|
2010-07-09 |
2015-09-29 |
Pfizer Limited |
Sulfonamide compounds
|
|
WO2012004743A1
(en)
|
2010-07-09 |
2012-01-12 |
Pfizer Limited |
Benzenesulfonamides useful as sodium channel inhibitors
|
|
CA2803118C
(en)
|
2010-07-09 |
2015-11-03 |
Pfizer Limited |
Sulfonamide derivatives as nav 1.7 inhibitors
|
|
EP2593432B1
(en)
|
2010-07-12 |
2014-10-22 |
Pfizer Limited |
N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
|
|
JP2013532186A
(ja)
*
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
WO2012007883A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
|
|
EP2593431B1
(en)
|
2010-07-12 |
2014-11-19 |
Pfizer Limited |
N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
|
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
US9120752B2
(en)
|
2010-07-16 |
2015-09-01 |
Purdue Pharma, L.P. |
Pyridine compounds as sodium channel blockers
|
|
NZ608116A
(en)
|
2010-09-13 |
2014-05-30 |
Novartis Ag |
Triazine-oxadiazoles
|
|
WO2012039657A1
(en)
|
2010-09-22 |
2012-03-29 |
Astrazeneca Ab |
Novel chromane compound for the treatment of pain disorders
|
|
EP2655330B1
(en)
|
2010-12-22 |
2016-02-10 |
Purdue Pharma LP |
Substituted pyridines as sodium channel blockers
|
|
WO2012095781A1
(en)
|
2011-01-13 |
2012-07-19 |
Pfizer Limited |
Indazole derivatives as sodium channel inhibitors
|
|
PL2670752T3
(pl)
|
2011-02-02 |
2016-09-30 |
|
Pirolopirazynowe spirocykliczne piperydynoamidy jako modulatory kanałów jonowych
|
|
CA2844799A1
(en)
|
2011-08-17 |
2013-02-21 |
Amgen Inc. |
Heteroaryl sodium channel inhibitors
|
|
JP2014528486A
(ja)
|
2011-10-13 |
2014-10-27 |
ケース ウエスタン リザーブ ユニバーシティ |
Ｒｘｒアゴニスト化合物および方法
|
|
JP2014532660A
(ja)
|
2011-10-28 |
2014-12-08 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおける選択活性を有するベンゾオキサゾリノン化合物
|
|
CN104093716B
(zh)
|
2011-10-31 |
2017-06-23 |
克赛农制药股份有限公司 |
联芳醚磺酰胺化合物及其作为治疗剂的用途
|
|
EP2773637B1
(en)
|
2011-10-31 |
2016-06-08 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
US9133131B2
(en)
|
2011-11-15 |
2015-09-15 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
US9012443B2
(en)
|
2011-12-07 |
2015-04-21 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
JP6058023B2
(ja)
*
|
2011-12-15 |
2017-01-11 |
ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ |
スルホンアミド誘導体
|
|
WO2013102826A1
(en)
*
|
2012-01-04 |
2013-07-11 |
Pfizer Limited |
N-aminosulfonyl benzamides
|
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
３位置換プロリン誘導体
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
US9346798B2
(en)
|
2012-02-13 |
2016-05-24 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
US9051311B2
(en)
|
2012-03-09 |
2015-06-09 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
WO2013146969A1
(ja)
|
2012-03-29 |
2013-10-03 |
第一三共株式会社 |
新規二置換シクロヘキサン誘導体
|
|
CA2874621A1
(en)
|
2012-05-22 |
2013-11-28 |
Genentech, Inc. |
N-substituted benzamides and their use in the treatment of pain
|
|
BR112015000187A2
(pt)
|
2012-07-06 |
2017-06-27 |
Genentech Inc |
benzamidas substituídas com n e métodos de uso das mesmas
|
|
TW201416362A
(zh)
|
2012-07-19 |
2014-05-01 |
Dainippon Sumitomo Pharma Co |
１－（環烷基羰基）脯胺酸衍生物
|
|
JP2015535251A
(ja)
|
2012-10-26 |
2015-12-10 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおいて選択的活性を有するベンゾオキサゾリノン化合物
|
|
BR112015008987A2
(pt)
|
2012-10-26 |
2017-07-04 |
Merck Sharp & Dohme |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
AR094667A1
(es)
|
2013-01-31 |
2015-08-19 |
Vertex Pharma |
Piridonamidas como moduladores de canales de sodio
|
|
US20140296266A1
(en)
|
2013-03-01 |
2014-10-02 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
WO2014153037A1
(en)
|
2013-03-14 |
2014-09-25 |
Genentech, Inc. |
Substituted triazolopyridines and methods of use thereof
|
|
US9493429B2
(en)
|
2013-03-15 |
2016-11-15 |
Genentech, Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
EP2968234B1
(en)
|
2013-03-15 |
2018-06-27 |
Chromocell Corporation |
Sodium channel modulators for the treatment of pain
|
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
|
MX2016006936A
(es)
|
2013-11-27 |
2016-10-05 |
Genentech Inc |
Benzamidas sustituidas y metodos para usarlas.
|